Class II · Moderate risk
Skin De-Tag
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
FDA drug recalls in 2020
Every FDA drug recall initiated in 2020, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.
930 recalls, newest first.
Class II · Moderate risk
Skin Cleanser
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Reman-AP
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Reman-8
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Reman-6
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Purple Gold Balm
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Purple Gold Balm
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Pimples Off Solution 60 ML
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Phlegm Off
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
PC Shrinker
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Pain Stopper
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Pain Away
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
New Life
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Nasal Ez
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Metabolic Booster. 500mg Capsules
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Max Slim
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Lupus Care
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Lump Shrinker
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Lipidtrol
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Immune-2100
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Herpes-P
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Herpes-G
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Herpes V Balm
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Herpes V Balm
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Herpes Soap
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs